Alex Gorsky earned a whopping $29.6M in 2020 as drugmaker pivoted around Covid-19 vaccine R&D
In nearly nine years helming J&J, CEO Alex Gorsky has watched his drugmaker morph into the single largest company in biopharma. But 2020 was a year like no other, requiring J&J’s massive machinery to pivot around developing a Covid-19 vaccine. For Gorsky, that effort proved particularly lucrative.
Gorsky raked in $29.58 million in compensation in 2020 — about a 16.6% pay bump from his overall pay package the prior year, according to an SEC filing. That’s also a 47% bump from Gorsky’s pay just two years ago, underscoring his sudden vault to the top of the charts for biopharma CEO pay.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.